000 | 02140 a2200625 4500 | ||
---|---|---|---|
005 | 20250516104414.0 | ||
264 | 0 | _c20130129 | |
008 | 201301s 0 0 eng d | ||
022 | _a1471-2261 | ||
024 | 7 |
_a10.1186/1471-2261-12-63 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHadi, Najah | |
245 | 0 | 0 |
_aVitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response. _h[electronic resource] |
260 |
_bBMC cardiovascular disorders _cAug 2012 |
||
300 |
_a63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
650 | 0 | 4 |
_aBenzoates _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCardiac Catheterization |
650 | 0 | 4 |
_aCatalase _xblood |
650 | 0 | 4 |
_aChemokine CCL2 _xblood |
650 | 0 | 4 |
_aCreatine Kinase, MB Form _xblood |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aDoxorubicin |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 |
_aHeart Diseases _xblood |
650 | 0 | 4 |
_aInflammation Mediators _xblood |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xblood |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMalondialdehyde _xblood |
650 | 0 | 4 |
_aMyocardium _ximmunology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aTelmisartan |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTroponin I _xblood |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
650 | 0 | 4 |
_aVitamin E _xpharmacology |
700 | 1 | _aYousif, Nasser Ghaly | |
700 | 1 | _aAl-amran, Fadhil G | |
700 | 1 | _aHuntei, Nadhem K | |
700 | 1 | _aMohammad, Bassim I | |
700 | 1 | _aAli, Sadiq J | |
773 | 0 |
_tBMC cardiovascular disorders _gvol. 12 _gp. 63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2261-12-63 _zAvailable from publisher's website |
999 |
_c22002816 _d22002816 |